Ophthalmic emulsion
US-10004685-B2 · Jun 26, 2018 · US
US10925892B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10925892-B2 |
| Application number | US-201916281316-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 21, 2019 |
| Priority date | Feb 21, 2018 |
| Publication date | Feb 23, 2021 |
| Grant date | Feb 23, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is directed to a lipid-based ophthalmic emulsion. The emulsion has an increased amount of a mucoadhesive galactomannan polymer that promotes a long-lasting protection against desiccation and moisture retention.
Opening claim text (preview).
We claim: 1. An ophthalmic emulsion, the emulsion comprising: water forming an aqueous phase; oil forming an oil phase; a hydrophilic surfactant having an HLB value from 10 to 18; a hydrophobic surfactant having an HLB value from 1 to 6; a charged phospholipid; borate; a mucoadhesive galactomannan polymer; and a preservative; wherein the mucoadhesive galactomannan polymer is present in the emulsion at a concentration of at least about 0.13 w/v % but no greater than 0.3 w/v %; wherein the preservative is free of a benzalkonium chloride; and wherein the ophthalmic emulsion has a hydration protection against desiccation of at least 10% higher than a control emulsion, wherein the control emulsion has the same composition of the ophthalmic emulsion except of containing 0.05 w/v % of the same galactomannan polymer used in the ophthalmic emulsion. 2. The emulsion as in claim 1 wherein the oil is a hydrocarbon selected from mineral oil, paraffin oil and petrolatum. 3. The emulsion as in claim 1 wherein the oil is at least 0.1 w/v % and no greater than 3 w/v % of the emulsion. 4. The emulsion as in claim 3 wherein the hydrophilic surfactant is present in the emulsion in an amount that is at least 0.08 w/v % and is no greater than about 0.8 w/v %. 5. The emulsion as in claim 4 wherein the hydrophilic surfactant is polyoxyethylene-40-stearate. 6. The emulsion as in claim 4 wherein the hydrophobic surfactant is at least about 0.01 w/v % and is no greater than 2.0 w/v %. 7. The emulsion as in claim 6 wherein the hydrophobic surfactant is a sorbitan tristearate. 8. The emulsion as in claim 1 wherein the mucoadhesive galactomannan polymer is selected from the group consisting of guar and hydroxypropyl guar. 9. The emulsion as in claim 8 wherein the charged phospholipid is an anionic phospholipid named dimyristoyl phosphatidylglycerol. 10. The emulsion as in claim 1 further comprising a borate/polyol buffer system. 11. The emulsion as in claim 10 wherein the preservative is a polymeric quaternary ammonium compound. 12. The emulsion as in claim 1 , wherein: i. the oil phase is in droplets within the aqueous phase and the droplets have a D 90 diameter that is no greater than about 700 nm but is at least 10 nm; and ii. the borate and galactomannan polymer cooperatively act to form a gel upon instillation of the emulsion in an eye of an individual. 13. The emulsion as in claim 12 , wherein the oil phase is in droplets within the aqueous phase and the droplets have a D 90 diameter that is no greater than about 500 nm but is at least 30 nm. 14. The emulsion as in claim 13 , wherein the oil phase is in droplets within the aqueous phase and the droplets have a D 90 diameter that is no greater than about 300 nm but is at least 50 nm.
containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids · CPC title
Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence) · CPC title
Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin · CPC title
Mixtures of compounds · CPC title
Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.